Shockwave treatment for medial tibial stress syndrome: A randomized double blind sham-controlled pilot trial

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

OBJECTIVES: Up to 35% of runners develop medial tibial stress syndrome (MTSS) which often results in lengthy disruption to training and sometimes affects daily activities. There is currently no high quality evidence to support any particular intervention for MTSS. This study aims to investigate the effect of shockwave therapy for MTSS.

DESIGN:A randomized, sham-controlled, pilot trial in a university-based health clinic including 28 active adults with MTSS.

METHODS:Intervention included standard dose shockwave therapy for the experimental group versus sham dose for the control group, delivered during Week 1-3, 5 and 9. Main outcome measures were pain measured during bone and muscle pressure as well as during running using a numerical rating scale (0-10) and running was measured as pain-limited distance (m), at Week 1 (baseline) and Week 10 (post-intervention). Self-perception of change was measured using the Global Rating of Change Scale (-7 to +7) at Week 10 (post-intervention).
RESULTS: Pain (palpation) was reduced in the experimental group by 1.1 out of 10.0 (95% CI -2.3 to 0.0) less than the control group. There were no other statistically significant differences between the groups.

CONCLUSIONS: Standard dose shockwave therapy is not more effective than sham dose at improving pain or running distance in MTSS. However, the sham dose may have had a clinical effect. Further investigation including a no intervention control is warranted to evaluate the effect of shockwave therapy in the management of MTSS
Original languageEnglish
Pages (from-to)220-224
Number of pages5
JournalJournal of Science and Medicine in Sport
Volume20
Issue number3
DOIs
Publication statusPublished - 2017

Fingerprint

Medial Tibial Stress Syndrome
Pain
Therapeutics
Control Groups
Investigational Therapies
Palpation
Group Psychotherapy
Self Concept
Outcome Assessment (Health Care)
Pressure
Bone and Bones
Muscles
Health

Cite this

@article{0a13034f1cc248109c42c1dbd23a2918,
title = "Shockwave treatment for medial tibial stress syndrome: A randomized double blind sham-controlled pilot trial",
abstract = "OBJECTIVES: Up to 35{\%} of runners develop medial tibial stress syndrome (MTSS) which often results in lengthy disruption to training and sometimes affects daily activities. There is currently no high quality evidence to support any particular intervention for MTSS. This study aims to investigate the effect of shockwave therapy for MTSS.DESIGN:A randomized, sham-controlled, pilot trial in a university-based health clinic including 28 active adults with MTSS.METHODS:Intervention included standard dose shockwave therapy for the experimental group versus sham dose for the control group, delivered during Week 1-3, 5 and 9. Main outcome measures were pain measured during bone and muscle pressure as well as during running using a numerical rating scale (0-10) and running was measured as pain-limited distance (m), at Week 1 (baseline) and Week 10 (post-intervention). Self-perception of change was measured using the Global Rating of Change Scale (-7 to +7) at Week 10 (post-intervention).RESULTS: Pain (palpation) was reduced in the experimental group by 1.1 out of 10.0 (95{\%} CI -2.3 to 0.0) less than the control group. There were no other statistically significant differences between the groups.CONCLUSIONS: Standard dose shockwave therapy is not more effective than sham dose at improving pain or running distance in MTSS. However, the sham dose may have had a clinical effect. Further investigation including a no intervention control is warranted to evaluate the effect of shockwave therapy in the management of MTSS",
keywords = "Extracorporeal shockwave therapy, Medial tibial stress syndrome, Shin splints",
author = "Phillip NEWMAN and Gordon WADDINGTON and Roger Adams",
year = "2017",
doi = "10.1016/j.jsams.2016.07.006",
language = "English",
volume = "20",
pages = "220--224",
journal = "Australian Journal of Science and Medicine in Sport",
issn = "1440-2440",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Shockwave treatment for medial tibial stress syndrome: A randomized double blind sham-controlled pilot trial

AU - NEWMAN, Phillip

AU - WADDINGTON, Gordon

AU - Adams, Roger

PY - 2017

Y1 - 2017

N2 - OBJECTIVES: Up to 35% of runners develop medial tibial stress syndrome (MTSS) which often results in lengthy disruption to training and sometimes affects daily activities. There is currently no high quality evidence to support any particular intervention for MTSS. This study aims to investigate the effect of shockwave therapy for MTSS.DESIGN:A randomized, sham-controlled, pilot trial in a university-based health clinic including 28 active adults with MTSS.METHODS:Intervention included standard dose shockwave therapy for the experimental group versus sham dose for the control group, delivered during Week 1-3, 5 and 9. Main outcome measures were pain measured during bone and muscle pressure as well as during running using a numerical rating scale (0-10) and running was measured as pain-limited distance (m), at Week 1 (baseline) and Week 10 (post-intervention). Self-perception of change was measured using the Global Rating of Change Scale (-7 to +7) at Week 10 (post-intervention).RESULTS: Pain (palpation) was reduced in the experimental group by 1.1 out of 10.0 (95% CI -2.3 to 0.0) less than the control group. There were no other statistically significant differences between the groups.CONCLUSIONS: Standard dose shockwave therapy is not more effective than sham dose at improving pain or running distance in MTSS. However, the sham dose may have had a clinical effect. Further investigation including a no intervention control is warranted to evaluate the effect of shockwave therapy in the management of MTSS

AB - OBJECTIVES: Up to 35% of runners develop medial tibial stress syndrome (MTSS) which often results in lengthy disruption to training and sometimes affects daily activities. There is currently no high quality evidence to support any particular intervention for MTSS. This study aims to investigate the effect of shockwave therapy for MTSS.DESIGN:A randomized, sham-controlled, pilot trial in a university-based health clinic including 28 active adults with MTSS.METHODS:Intervention included standard dose shockwave therapy for the experimental group versus sham dose for the control group, delivered during Week 1-3, 5 and 9. Main outcome measures were pain measured during bone and muscle pressure as well as during running using a numerical rating scale (0-10) and running was measured as pain-limited distance (m), at Week 1 (baseline) and Week 10 (post-intervention). Self-perception of change was measured using the Global Rating of Change Scale (-7 to +7) at Week 10 (post-intervention).RESULTS: Pain (palpation) was reduced in the experimental group by 1.1 out of 10.0 (95% CI -2.3 to 0.0) less than the control group. There were no other statistically significant differences between the groups.CONCLUSIONS: Standard dose shockwave therapy is not more effective than sham dose at improving pain or running distance in MTSS. However, the sham dose may have had a clinical effect. Further investigation including a no intervention control is warranted to evaluate the effect of shockwave therapy in the management of MTSS

KW - Extracorporeal shockwave therapy

KW - Medial tibial stress syndrome

KW - Shin splints

UR - http://www.scopus.com/inward/record.url?scp=84994779354&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/shockwave-treatment-medial-tibial-stress-syndrome-randomized-double-blind-shamcontrolled-pilot-trial

U2 - 10.1016/j.jsams.2016.07.006

DO - 10.1016/j.jsams.2016.07.006

M3 - Article

VL - 20

SP - 220

EP - 224

JO - Australian Journal of Science and Medicine in Sport

JF - Australian Journal of Science and Medicine in Sport

SN - 1440-2440

IS - 3

ER -